Strategic Fit EuroMed, now a Scapa Healthcare company, specializes in hydrocolloid wound care technology with in-house R&D, QC, and a state-of-the-art ISO certified manufacturing facility. Potential sales opportunity: position a turnkey hydrocolloid wound care collaboration or private-label manufacturing partnership to expand South/North American distribution and private-label programs.

Private-Label Capabilities With a long history of providing hundreds of millions in premium USA-made adhesives on a private-label basis, EuroMed offers ready-made private-label opportunities for consumer and professional wound care products. Potential sales opportunity: target OEMs and private-label brands seeking reliable US manufacturing and scalable supply for private-label hydrocolloid products.

Global Partnership As part of Scapa Healthcare, a global outsource partner in Advanced Wound Care, Consumer Wellness, and Wearable Medical Devices, EuroMed can leverage a broad technology portfolio including Soft-Pro adhesives and Bioflex materials. Potential sales opportunity: propose cross-sell of wound care and wearable device adhesive solutions to existing market leaders and new entrants in healthcare products.

Expansion Footprint EuroMed operates a large-scale, clean-room manufacturing facility and regional presence in New York, with historical expansion through Scapa’s footprint, including Tennessee facility investments. Potential sales opportunity: propose scaling manufacturing capacity or co-development of new hydrocolloid skincare products to meet growing demand in North America and partner pipelines.

Growth Signals Revenue is in the mid-range of $100M-$250M with a workforce of 51-200 employees, indicating a scalable operations model suitable for higher-volume partnerships. Potential sales opportunity: offer capacity-scaling agreements, performance-based collaborations, or technology licensing to accelerate market share gains in advanced wound care segments.